![David Tierney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Tierney
Directeur/Membre du Conseil chez
CATALYST PHARMACEUTICALS, INC.
Fortune : 12 M $ au 31/05/2026
Profil
David S.
Tierney was the founder of Oceana Therapeutics, Inc. (founded in 2008) and held the title of President, Chief Operating Officer & Director in 2011.
He is currently the President, CEO, Secretary, Treasurer & Director at Aramis Biosciences, Inc., an Independent Director at Catalyst Pharmaceuticals, Inc. since 2002, and a Director at Bimeda, Inc. since 2018.
Dr. Tierney has previously held positions as the President, Chief Executive Officer & Director at Valera Pharmaceuticals, Inc. from 2000 to 2007, President & Chief Executive Officer at Icon Bioscience, Inc. from 2014 to 2018, Chief Executive Officer at Pharma Two B Ltd. in 2020, President & Chief Executive Officer at BioPharmX Corp.
from 2019 to 2020, and Senior Vice President-Drug Development at Roberts Pharmaceutical Corp.
from 1997 to 2000.
He has also served as a Director at Bioject Medical Technologies, Inc., Able Laboratories, Inc., Apricus Biosciences, Inc., Elan Pharmaceuticals LLC, Viatar CTC Solutions, Inc., Palvella Therapeutics, Inc., and Zevra Therapeutics, Inc. Additionally, Dr. Tierney was a Venture Partner at Signet Healthcare Partners LLC in 2013 and President of Biovail Technologies Ltd. in 2000.
Dr. Tierney obtained his doctorate degree from the Royal College of Surgeons in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 383 314 ( 0,31 % ) | 12 M $ | 31/05/2026 |
Postes actifs de David Tierney
| Sociétés | Poste | Début |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/10/2002 |
Bimeda, Inc.
 Bimeda, Inc. Pharmaceuticals: MajorHealth Technology Manufactures veterinary pharmaceuticals and animal health care products | Directeur/Membre du Conseil | 01/06/2018 |
Aramis Biosciences, Inc.
 Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunology and ophthalmology biopharmaceuticals | Directeur Général | - |
Anciens postes connus de David Tierney
| Sociétés | Poste | Fin |
|---|---|---|
Pharma Two B Ltd.
 Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Manufactures combination drugs for neurological disorders | Directeur Général | 01/01/2021 |
| TREX WIND-DOWN, INC. | Directeur Général | 01/01/2020 |
Icon Bioscience, Inc.
 Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Directeur Général | 01/03/2018 |
Signet Healthcare Partners LLC
 Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners invests in public and private companies across the globe. The fund targets companies operating in the fields of generic & specialty pharmaceuticals, pharmaceuticals services, medical devices and diagnostics. It provides financing for later and growth stage capital requirements with an investment size of USD 10 - 15 million. It makes co-investments and acts as lead investor with majority and minority investments. It also takes a seat on the board of directors. | Corporate Officer/Principal | 01/03/2014 |
Oceana Therapeutics, Inc.
 Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and medical devices | Fondateur | 01/12/2011 |
Formation de David Tierney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Bioject Medical Technologies, Inc.
 Bioject Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures needle-free injection therapy systems | Health Technology |
Roberts Pharmaceutical Corp.
 Roberts Pharmaceutical Corp. Pharmaceuticals: OtherHealth Technology Provides pharmaceutical products | Health Technology |
Able Laboratories, Inc.
 Able Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Health Technology |
Valera Pharmaceuticals, Inc.
 Valera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders | Health Technology |
Signet Healthcare Partners LLC
Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners invests in public and private companies across the globe. The fund targets companies operating in the fields of generic & specialty pharmaceuticals, pharmaceuticals services, medical devices and diagnostics. It provides financing for later and growth stage capital requirements with an investment size of USD 10 - 15 million. It makes co-investments and acts as lead investor with majority and minority investments. It also takes a seat on the board of directors. | Finance |
Catalyst Pharmaceuticals, Inc.
 Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Icon Bioscience, Inc.
Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
Viatar CTC Solutions, Inc.
 Viatar CTC Solutions, Inc. Medical SpecialtiesHealth Technology Develops and markets products to collect cancer cells for molecular diagnostics | Health Technology |
Bimeda, Inc.
Bimeda, Inc. Pharmaceuticals: MajorHealth Technology Manufactures veterinary pharmaceuticals and animal health care products | Health Technology |
Royal College of Surgeons
 Royal College of Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biovail Technologies Ltd.
 Biovail Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Bausch Health Cos., Inc., Biovail Technologies Ltd. is a company based in Chantilly, VA. | Commercial Services |
Oceana Therapeutics, Inc.
Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and medical devices | Health Technology |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Manufactures combination drugs for neurological disorders | Health Technology |
BioPharmX Corp.
 BioPharmX Corp. BiotechnologyHealth Technology Develops drug-delivery products | Health Technology |
Palvella Therapeutics, Inc.
 Palvella Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing new therapeutic agents for diseases suffered by patients that lack any treatment choices | Health Technology |
Aramis Biosciences, Inc.
Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunology and ophthalmology biopharmaceuticals | Health Technology |
